4.1. Photo physical properties of probe
The probe has phenolic -OH which binds with the acid group in the phenylalanine as electron donor by hydrogen bond through ICT (Internal Charge Transfer) mechanism selectively. Initially the probe shows bright yellow color and with the addition of phenylalanine complete quenching has been observed. [21] (Scheme.1)
The absorption spectrum of probe shows peaks at 411nm and 438nm in 1x10-6M ACN/PBS (v/v, 1:9) at neutral pH and the emission spectrum exhibits peak at 548nm, which is mainly characteristics of n→p* transition (Figure.1, (i) & (ii)).
This comparative experiments have been performed to discriminate the phenylalanine by the probe in the presence of other interference competitors (Figure. 2). The selective detection of phenylalanine at 500µM concentration has been clearly revealed. Upon the addition of different concentrations of phenylalanine (20nM-500µM) to the probe, decrease in the absorbance has been observed (Figure. 3). Thus, the Figure.4 shows the linearly decreasing absorbance of the complex. [22]
The probe and analyte exhibit complete fluorescence quenching (TURN- OFF response) selectively compared with other competitors (Figure. 5). Further addition of phenylalanine (20nM -500mM) to probe, gradually decreases the fluorescent intensity with hypsochromic shift. (Figure. 6) The corresponding bar diagram shows selectivity towards phenylalanine, in which no spectral change has been observed with other competitors. (Figure. 7) It clearly reveals the high selectivity to phenylalanine by optical experimental method. [23]
The competitive experiments for the probe and analyte with interfering other biomolecules such as leucine, asparagine, urea, creatinine, ascorbic acid, cysteine, tryptophan, alanine, glutamine and albumin are carried out. These experiments indicate that phenylalanine is binding with probe. Other biomolecules do not interfere during the phenylalanine binding with probe, as represented in the bar diagram. (Figure. 8) [24]
The job’s plot plotted between mole fraction (same concentration of probe and analyte) vs fluorescence intensity. Binding stoichiometric ratio of probe with phenylalanine has been arrived by fractional addition method. From the jobs plot, the binding ratio of probe: phenylalanine is found to be 1:2 (Figure. 9) [25].
The pH dependance has been studied using Phosphate buffer solution (PBS). The different solutions were prepared at various pH level (pH 2-12). At basic medium (pH 8-12), deprotonation of the probe leads to less interaction with phenylalanine. At the neutral pH, high fluorescent intensity is observed while adding phenylalanine with complete quenching. Hence, all other experiments have been performed at neutral pH condition (Figure.S5).[26]
Colorimetric and Fluorimetric Biosensor for Phenylalanine
Initially the probe is dissolved in acetonitrile (ACN) solution. Then, the addition of phenylalanine to the probe leads to the colour changes from yellow to dark brown observed by naked eye. Under the UV lamp, the colour changes observed from bright yellow fluorescence. But, there is no colour change obseved for the other competitors with probe (Figure.12). From the colorimetric and fluorimetric techniques, it is confirmed that there is a selective interaction between the probe and phenylalanine at nanomolar concentration at neutral pH. [27, 28]
Test Strip Method:
Test strip method is a confirmation method to selective detection of phenylalanine. Filter papers were soaked overnight into the probe solution (a), probe with analyte (b) and probe with other competitors (c). The strips (a) and (c) shows yellow color and colourless, respectively. No color change has been observed with the other competitors (figure c) under UV lamp. It can be concluded that the pyridine derivative selectively detect the phenylalanine. [29]
5. Phenylalanine sensitivity in human biofluids
The numerical assessment for PA has been employed in human biological fluids such as urine and blood serum (Fig. 12 and 13) by standard addition method. Spiking the known concentration of PA (50 nM, 100 nM, 200 nM, 300 nM, 400 nM, 500 nM, 50 µM, 100 µM, 200 µM, 300 µM, 400 µM and 500 µM) into the blood and urine samples and incubate for 15-20 mins. From spectral measurement, the development of biosensor towards the detection of PA in human blood and urine sample is thus achieved. (Fig. 8 and 9) [30, 31]
Literature report for phenylalanine sensor:
Sl.No
|
Types ofsensor platform
|
Techniques
|
LOD
|
References
|
1
|
Electrochemical sensor by using polyaniline modified carbon electrode baesd on β-cyclodextrin incorporated multiwall carbon nano tube and imprinted sol-gel film
|
Electrochemical
Sensor
|
1.0×10-9 mol L-1
|
[32]
|
2
|
Electrochemical sensor by molecular imprinted techniques
|
Electrochemical sensor
|
1.0×10-9 M
|
[33]
|
3
|
Fluorescence quenching by using combination of cucurbit[7]uril (CB[7]) with palmatine hydrochloride.
|
Fluorescence quenching method
|
1.27×10-8 mol/L
|
[34]
|
4
|
Electrochemical enantioselectivity sensor by using Graphene-ferrocene functionalized cyclodextrin modified electrode
|
Electrochemical sensor
|
27 nM and 52 nM
|
[35]
|
5
|
A novel colorimetric and fluorescent multifunctional chemo-sensor by using 4-bromo-2-hydroxyben Rhodamine B hydrazide
(RHBr).
|
colorimetric and fluorescent chemo sensor
|
3.0×10-7 M
|
[36]
|
6
|
potentiometric chiral sensor based on
crosslinkedpolymethylacrylic acid–polycarbazole hybrid molecularly imprinted polymer.
|
Potentiometric chiral sensor
|
1.37 µM
|
[37]
|
7
|
Spectro fluorimetric method based on fluorescence Enhancement of europium ion immobilized with sol–gel
|
Spectrofluorimetric
Method
|
5.2×10−6 molL−1
|
[38]
|
8
|
Electochemicalenantioselectivity biosensor based on β-Cyclodextrin immobilized on reduced graphene
Oxide
|
Electrochemical biosensor
|
0.10 µM and 0.15 µM
|
[39]
|
9
|
Biosensor by using fluorescence protein
|
Biosensor
|
3.7 µM
|
[40]
|
10
|
Electrochemical biosensor by Gold Electrode Modified with Graphene Oxide Nanosheets
and Chitosan
|
Electrochemical biosensor
|
416 mM
|
[41]
|
11
|
Optical biosensor by using fluorescent organic compound
|
Optical biosensor
|
0.32 nM
|
Present work
|
6. DFT studies
The experimental finding of pyridine based organic probe detect the PA at lower concentration were further explored using DFT atomic level simulation. All the calculations have been carried out using Gaussian 09 [42] suite of program. The probe and complex were optimized at B3LYP/6-31g(d,p)[43] level of theory in the gas phase. The optimized structure of probe and complex were further confirmed with no imaginary frequencies using frequency calculation. The optimized structure of probe and complex were placed in Figure 10 (see Fig 10(a), 10(b)). The single point energy calculation of frontier molecular orbital and electrostatic potential on the optimized structure of pyridine based organic probe and PA complex were employed at B3LYP/6-31g(d,p) level in the gas phase. The electrostatic potential of probe was placed in Figure 10 (c). It can be observed from Figure 10(c) that the red region represents the electrophilic nature and blue region represents the electrophobic nature. The frontier molecular orbital (FMO) structure of probe and complex was placed in the Figure 11 (a) and 11(b), respectively. The oscillator strength at HOMO-1 to LUMO+1 observed to be 0.519 for the organic probe and the molecular orbital gap was calculated as 4.52 eV. The computed wave length for the probe was 300.88 nm. Moreover, the oscillator strength at HOMO to LUMO+2 observed to be 0.769 for the complex and the molecular orbital gap was calculated to be 3.82 eV. The computed wave length for the complex was 369.43 nm. The observed lower band gap in the complex was confirmed the biomolecule interaction with organic probe and complex formation. In probe, at HOMO-1 the electron cloud was observed at both the phenolic moiety and at LUMO+1 was observed at pyridine moiety. However, at HOMO and LUMO+2 levels the electron cloud in the complex was observed at the phenolic and pyridine moiety.